4//SEC Filing
Segal Lloyd Mitchell 4
Accession 0001209191-23-006062
CIK 0001808158other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:44 PM ET
Size
8.6 KB
Accession
0001209191-23-006062
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-30+344,200→ 344,200 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (344,200 underlying) - Award
Common Shares
2023-01-30+78,550→ 84,677 total
Holdings
- 94,466(indirect: See footnote)
Common Shares
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 398 shares and 729 shares acquired on August 13, 2021 and February 15, 2022, respectively, under the Issuer's employee stock purchase plan.
- [F3]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001477123
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:44 PM ET
- Size
- 8.6 KB